Cargando…
Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates
BACKGROUND: The development of regenerative therapy for human spinal cord injury (SCI) is dramatically restricted by two main challenges: the need for a safe source of functionally active and reproducible neural stem cells and the need of adequate animal models for preclinical testing. Direct reprog...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176843/ https://www.ncbi.nlm.nih.gov/pubmed/34136075 http://dx.doi.org/10.4252/wjsc.v13.i5.452 |
_version_ | 1783703314596102144 |
---|---|
author | Baklaushev, Vladimir P Durov, Oleg V Kalsin, Vladimir A Gulaev, Eugene V Kim, Sergey V Gubskiy, Ilya L Revkova, Veronika A Samoilova, Ekaterina M Melnikov, Pavel A Karal-Ogly, Dzhina D Orlov, Sergey V Troitskiy, Alexander V Chekhonin, Vladimir P Averyanov, Alexander V Ahlfors, Jan-Eric |
author_facet | Baklaushev, Vladimir P Durov, Oleg V Kalsin, Vladimir A Gulaev, Eugene V Kim, Sergey V Gubskiy, Ilya L Revkova, Veronika A Samoilova, Ekaterina M Melnikov, Pavel A Karal-Ogly, Dzhina D Orlov, Sergey V Troitskiy, Alexander V Chekhonin, Vladimir P Averyanov, Alexander V Ahlfors, Jan-Eric |
author_sort | Baklaushev, Vladimir P |
collection | PubMed |
description | BACKGROUND: The development of regenerative therapy for human spinal cord injury (SCI) is dramatically restricted by two main challenges: the need for a safe source of functionally active and reproducible neural stem cells and the need of adequate animal models for preclinical testing. Direct reprogramming of somatic cells into neuronal and glial precursors might be a promising solution to the first challenge. The use of non-human primates for preclinical studies exploring new treatment paradigms in SCI results in data with more translational relevance to human SCI. AIM: To investigate the safety and efficacy of intraspinal transplantation of directly reprogrammed neural precursor cells (drNPCs). METHODS: Seven non-human primates with verified complete thoracic SCI were divided into two groups: drNPC group (n = 4) was subjected to intraspinal transplantation of 5 million drNPCs rostral and caudal to the lesion site 2 wk post injury, and lesion control (n = 3) was injected identically with the equivalent volume of vehicle. RESULTS: Follow-up for 12 wk revealed that animals in the drNPC group demonstrated a significant recovery of the paralyzed hindlimb as well as recovery of somatosensory evoked potential and motor evoked potential of injured pathways. Magnetic resonance diffusion tensor imaging data confirmed the intraspinal transplantation of drNPCs did not adversely affect the morphology of the central nervous system or cerebrospinal fluid circulation. Subsequent immunohistochemical analysis showed that drNPCs maintained SOX2 expression characteristic of multipotency in the transplanted spinal cord for at least 12 wk, migrating to areas of axon growth cones. CONCLUSION: Our data demonstrated that drNPC transplantation was safe and contributed to improvement of spinal cord function after acute SCI, based on neurological status assessment and neurophysiological recovery within 12 wk after transplantation. The functional improvement described was not associated with neuronal differentiation of the allogeneic drNPCs. Instead, directed drNPCs migration to the areas of active growth cone formation may provide exosome and paracrine trophic support, thereby further supporting the regeneration processes. |
format | Online Article Text |
id | pubmed-8176843 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-81768432021-06-15 Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates Baklaushev, Vladimir P Durov, Oleg V Kalsin, Vladimir A Gulaev, Eugene V Kim, Sergey V Gubskiy, Ilya L Revkova, Veronika A Samoilova, Ekaterina M Melnikov, Pavel A Karal-Ogly, Dzhina D Orlov, Sergey V Troitskiy, Alexander V Chekhonin, Vladimir P Averyanov, Alexander V Ahlfors, Jan-Eric World J Stem Cells Basic Study BACKGROUND: The development of regenerative therapy for human spinal cord injury (SCI) is dramatically restricted by two main challenges: the need for a safe source of functionally active and reproducible neural stem cells and the need of adequate animal models for preclinical testing. Direct reprogramming of somatic cells into neuronal and glial precursors might be a promising solution to the first challenge. The use of non-human primates for preclinical studies exploring new treatment paradigms in SCI results in data with more translational relevance to human SCI. AIM: To investigate the safety and efficacy of intraspinal transplantation of directly reprogrammed neural precursor cells (drNPCs). METHODS: Seven non-human primates with verified complete thoracic SCI were divided into two groups: drNPC group (n = 4) was subjected to intraspinal transplantation of 5 million drNPCs rostral and caudal to the lesion site 2 wk post injury, and lesion control (n = 3) was injected identically with the equivalent volume of vehicle. RESULTS: Follow-up for 12 wk revealed that animals in the drNPC group demonstrated a significant recovery of the paralyzed hindlimb as well as recovery of somatosensory evoked potential and motor evoked potential of injured pathways. Magnetic resonance diffusion tensor imaging data confirmed the intraspinal transplantation of drNPCs did not adversely affect the morphology of the central nervous system or cerebrospinal fluid circulation. Subsequent immunohistochemical analysis showed that drNPCs maintained SOX2 expression characteristic of multipotency in the transplanted spinal cord for at least 12 wk, migrating to areas of axon growth cones. CONCLUSION: Our data demonstrated that drNPC transplantation was safe and contributed to improvement of spinal cord function after acute SCI, based on neurological status assessment and neurophysiological recovery within 12 wk after transplantation. The functional improvement described was not associated with neuronal differentiation of the allogeneic drNPCs. Instead, directed drNPCs migration to the areas of active growth cone formation may provide exosome and paracrine trophic support, thereby further supporting the regeneration processes. Baishideng Publishing Group Inc 2021-05-26 2021-05-26 /pmc/articles/PMC8176843/ /pubmed/34136075 http://dx.doi.org/10.4252/wjsc.v13.i5.452 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Basic Study Baklaushev, Vladimir P Durov, Oleg V Kalsin, Vladimir A Gulaev, Eugene V Kim, Sergey V Gubskiy, Ilya L Revkova, Veronika A Samoilova, Ekaterina M Melnikov, Pavel A Karal-Ogly, Dzhina D Orlov, Sergey V Troitskiy, Alexander V Chekhonin, Vladimir P Averyanov, Alexander V Ahlfors, Jan-Eric Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates |
title | Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates |
title_full | Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates |
title_fullStr | Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates |
title_full_unstemmed | Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates |
title_short | Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates |
title_sort | disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates |
topic | Basic Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176843/ https://www.ncbi.nlm.nih.gov/pubmed/34136075 http://dx.doi.org/10.4252/wjsc.v13.i5.452 |
work_keys_str_mv | AT baklaushevvladimirp diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates AT durovolegv diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates AT kalsinvladimira diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates AT gulaeveugenev diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates AT kimsergeyv diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates AT gubskiyilyal diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates AT revkovaveronikaa diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates AT samoilovaekaterinam diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates AT melnikovpavela diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates AT karaloglydzhinad diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates AT orlovsergeyv diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates AT troitskiyalexanderv diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates AT chekhoninvladimirp diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates AT averyanovalexanderv diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates AT ahlforsjaneric diseasemodifyingtreatmentofspinalcordinjurywithdirectlyreprogrammedneuralprecursorcellsinnonhumanprimates |